[Form 4] PepGen Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PepGen Inc. executive Paul Streck, EVP and Head of R&D, reported awards of equity-based compensation. He received stock options covering 196,500 shares at an exercise price of $0.00 per share and 50,300 shares of common stock in the form of restricted stock units. The RSUs vest in equal annual installments over four years starting on March 1, 2027, while the option vests 25% on the one-year anniversary of the grant date and the remaining 75% in 36 equal monthly installments, in each case conditioned on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
STRECK PAUL
Role
EVP, Head of R&D
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 196,500 | $0.00 | -- |
| Grant/Award | Common Stock | 50,300 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 196,500 shares (Direct);
Common Stock — 78,105 shares (Direct)
Footnotes (1)
- Consists of 50,300 restricted stock units ("RSUs"), each representing the contingent right to receive one share of Common Stock upon vesting. The RSUs vest in equal annual installments over four years, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date. This option shall vest and become exercisable as follows: 25% of the shares on the one-year anniversary of the Grant Date, with the remaining 75% vesting and becoming exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date.